Navigation Links
PrecisionMD Launches NEW Anti-Redness Product - DermaChromatic
Date:12/7/2012

NEW YORK, Dec. 7, 2012 /PRNewswire/ -- PrecisionMD, the developer of innovative therapeutic and cosmetic skincare solutions, is excited to announce the Fall 2012 launch of DermaChromatic, the only product that uses a patent-pending copper-chlorophyllin anti-redness technology to visibly improve skin redness in as little as two weeks.

(Logo: http://photos.prnewswire.com/prnh/20121207/NY24133LOGO )

Over 13 million people suffer from redness, a chronic skin concern that can affect self-esteem and severely disrupt a patient's life. In a recent study by Dr. Lillian Ritu and Dr. Perry Robins of NY, DermaChromatic was shown to reduce the appearance of redness by 54 percent in just two weeks and by 68 percent in four weeks using a special camera that measures redness in the skin.  The formula also helps reduce oiliness and reduces the appearance of pore size, conditions often associated with redness.

How does it work? DermaChromatic uses an exclusive copper-chlorophyllin complex that helps neutralize free radicals that cause red, irritated skin. Copper also helps even skin tone and reduce oiliness. The complex has been loaded into spherical lipid shells called liposomes that allow for the controlled release of the ingredients into skin. The result: more effective redness relieving results more quickly.

"DermaChromatic produces simply remarkable results in my practice. My patients with red and blotchy facial skin have noticed a dramatic reduction in the redness of their skin, plus they love the way the product feels as it's applied," says David B. Vasily, M.D., FAAD, co-inventor of DermaChromatic technology and board-certified dermatologist, Bethlehem, PA.

DermaChromatic is a non-irritating, oil-free, fragrance-free and paraben-free gel that works well on all skin types.

DermaChromatic is available at Dermatologist and other Aesthetic MD offices. For more information, visit www.precisionmdskin.com or call 1-888-423-5349.  For before and after images see: http://www.precisionmdskin.com/dermachromatic/before-after/.

PrecisionMD is the sole distributor in the U.S. of DermaChromatic. To find an authorized PrecisionMD physician in your area, visit www.precisionmdskin.com/find-physician.

About PrecisionMD
Headquartered in New York, NY, PrecisionMD is committed to developing, manufacturing and marketing innovative therapeutic and cosmetic skincare solutions that meet the dispensing needs of our physician partners and their patients, with brands including Vivatia, Dermaceutic, Relastin, DermaChromatic and CelfixDNA. PrecisionMD is supported by the shared state of the art FDA-approved research and production facilities of Precision Dermatology, Inc. in Cumberland, RI. PrecisionMD's President, Chief Executive Officer and Founder, Mr. Jeffrey Nugent, has over 25 years of dermatology and consumer skin and beauty care experience.


'/>"/>
SOURCE PrecisionMD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Quebec Clinic Launches Canadian Use of Elektas Agility Beam-Shaping Innovation for Radiation Therapy of Cancer
2. Separation Design Group Launches Crowd-Funding Campaign for Worlds Smallest Oxygen Machine
3. Alacrita Launches 2012 Charity Auction of One-to-One Lunches with Senior Executives from the Pharmaceutical Industry
4. Noverant Launches Major Learning Management System Upgrade
5. BlipCare Launches The Next Generation Wireless Weight Scale That Reminds Users To Take Their Readings
6. Elsevier Launches New Open Access Journal - Epilepsy & Behavior Case Reports
7. Unfors RaySafe launches new solution to lower patient dose
8. eCardio Launches Instructional Patient Video Series to Enhance Monitoring Experience and Improve Patient Compliance
9. Musculoskeletal Network Launches Special Coverage of FDA Biosimilars Policy
10. ePharmaSolutions Launches an Innovative Patient Recruitment Application for Windows 8
11. Coloplast Launches the Innovative Altis Single Incision Sling System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
(Date:12/8/2016)... CAMBRIDGE, Mass. , Dec. 8, 2016 /PRNewswire/ ... that it has obtained proof-of-mechanism for neflamapimod (previously ... recently completed Phase 2a clinical trials that demonstrated ... from Study 302 (12-week treatment) and Study 303 ... the Clinical Trials in Alzheimer,s Disease (CTAD) scientific ...
(Date:12/8/2016)... -- A Small Business Innovative Research (SBIR) grant has ... to Phoenix -based NeuroEM Therapeutics, Inc. ... will seek to determine an optimal set of treatment ... to treat Alzheimer,s Disease. The grant will also investigate ... other neurologic disorders such as Parkinson,s Disease and PTSD. ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
(Date:12/8/2016)... ... , ... Coppin Insurance Agency, an insurance and financial planning firm based in ... area, is embarking on a charity drive with the goal of providing support and ... Food Bank of Southwest Florida works to provide fresh and nutritious food free of ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... with the announcement that it is one of the early adopters completing EU-U.S. Privacy ... Framework is designed to provide companies on both sides of the Atlantic with a ...
(Date:12/7/2016)... Alexandria, VA (PRWEB) , ... December 07, 2016 ... ... nation are celebrating the passage of the most comprehensive mental health systems reform ... Congress, the support of the President, and the commitment of our elected officials ...
Breaking Medicine News(10 mins):